Xiaofei Ye

1.5k total citations
9 papers, 135 citations indexed

About

Xiaofei Ye is a scholar working on Pathology and Forensic Medicine, Genetics and Oncology. According to data from OpenAlex, Xiaofei Ye has authored 9 papers receiving a total of 135 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pathology and Forensic Medicine, 5 papers in Genetics and 4 papers in Oncology. Recurrent topics in Xiaofei Ye's work include Lymphoma Diagnosis and Treatment (6 papers), Chronic Lymphocytic Leukemia Research (5 papers) and Viral-associated cancers and disorders (3 papers). Xiaofei Ye is often cited by papers focused on Lymphoma Diagnosis and Treatment (6 papers), Chronic Lymphocytic Leukemia Research (5 papers) and Viral-associated cancers and disorders (3 papers). Xiaofei Ye collaborates with scholars based in China, Sweden and United States. Xiaofei Ye's co-authors include Qiang Pan‐Hammarström, Weicheng Ren, Kui Wu, Man Nie, Guibo Li, Lei Wang, Zhiming Li, Yuyao Wang, Dongbing Liu and Xiaobo Li and has published in prestigious journals such as The Journal of Experimental Medicine, The Journal of Immunology and Cell Reports.

In The Last Decade

Xiaofei Ye

9 papers receiving 133 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaofei Ye China 7 69 61 61 43 33 9 135
Catalina Amador United States 7 64 0.9× 39 0.6× 46 0.8× 40 0.9× 17 0.5× 19 132
Stefan Köhrer Austria 4 54 0.8× 69 1.1× 42 0.7× 30 0.7× 41 1.2× 11 153
Jennifer A. Arzt United States 4 58 0.8× 64 1.0× 52 0.9× 27 0.6× 65 2.0× 5 151
Immacolata Attolico Italy 6 28 0.4× 27 0.4× 44 0.7× 29 0.7× 47 1.4× 17 146
Olga Stehlíková Czechia 7 40 0.6× 51 0.8× 22 0.4× 52 1.2× 56 1.7× 14 146
Muhammed B. Sabdia Australia 6 66 1.0× 36 0.6× 96 1.6× 55 1.3× 11 0.3× 17 144
Jared Henderson United States 5 52 0.8× 38 0.6× 55 0.9× 48 1.1× 45 1.4× 14 131
Zlatana Pasalic Germany 4 37 0.5× 93 1.5× 33 0.5× 45 1.0× 68 2.1× 6 169
Rianne Veenstra Netherlands 7 113 1.6× 28 0.5× 112 1.8× 100 2.3× 18 0.5× 9 180
Alejandro Medina Spain 6 40 0.6× 45 0.7× 32 0.5× 12 0.3× 32 1.0× 15 105

Countries citing papers authored by Xiaofei Ye

Since Specialization
Citations

This map shows the geographic impact of Xiaofei Ye's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaofei Ye with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaofei Ye more than expected).

Fields of papers citing papers by Xiaofei Ye

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaofei Ye. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaofei Ye. The network helps show where Xiaofei Ye may publish in the future.

Co-authorship network of co-authors of Xiaofei Ye

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaofei Ye. A scholar is included among the top collaborators of Xiaofei Ye based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaofei Ye. Xiaofei Ye is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Ma, Yingxia, Tian-Ze Li, Haijun Yang, et al.. (2025). Synthesis of a novel amorphous metal-organic framework containing rich N and S groups for efficient adsorption of Ag(I) in aqueous solutions. Journal of Solid State Chemistry. 344. 125193–125193. 2 indexed citations
2.
Du, Likun, Valentyn Oksenych, Hui Wan, et al.. (2024). Orientation Regulation of Class-switch Recombination in Human B Cells. The Journal of Immunology. 213(8). 1093–1104. 2 indexed citations
3.
Ren, Weicheng, Hui Wan, Mattias Berglund, et al.. (2023). Genetic and transcriptomic analyses of diffuse large B-cell lymphoma patients with poor outcomes within two years of diagnosis. Leukemia. 38(3). 610–620. 9 indexed citations
5.
Ye, Xiaofei, Lei Wang, Man Nie, et al.. (2022). A single-cell atlas of diffuse large B cell lymphoma. Cell Reports. 39(3). 110713–110713. 53 indexed citations
6.
Ren, Weicheng, Xianhuo Wang, Ming‐Yu Yang, et al.. (2022). Distinct clinical and genetic features of hepatitis B virus–associated follicular lymphoma in Chinese patients. Blood Advances. 6(9). 2731–2744. 10 indexed citations
7.
Nie, Man, Likun Du, Weicheng Ren, et al.. (2021). Genome-wide CRISPR screens reveal synthetic lethal interaction between CREBBP and EP300 in diffuse large B-cell lymphoma. Cell Death and Disease. 12(5). 419–419. 20 indexed citations
8.
Ye, Xiaofei, Weicheng Ren, Dongbing Liu, et al.. (2020). Genome-wide mutational signatures revealed distinct developmental paths for human B cell lymphomas. The Journal of Experimental Medicine. 218(2). 24 indexed citations
9.
Ren, Weicheng, Wei Li, Xiaofei Ye, Hui Liu, & Qiang Pan‐Hammarström. (2017). Distinct subtype distribution and somatic mutation spectrum of lymphomas in East Asia. Current Opinion in Hematology. 24(4). 367–376. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026